Cargando…

Editorial: Ion Channels: Therapeutic Targets for Neurological Disease

Detalles Bibliográficos
Autores principales:	Hou, Panpan, Du, Xiaona, An, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636780/ https://www.ncbi.nlm.nih.gov/pubmed/34867195 http://dx.doi.org/10.3389/fnmol.2021.797327

Ejemplares similares

Editorial: Ion channels and transporters in epilepsy: From genes and mechanisms to disease-targeted therapies
por: He, Hailan, et al.
Publicado: (2022)

Editorial: Mitochondrial therapy in neurological diseases
por: Chang, Jui-Chih, et al.
Publicado: (2022)

Dysfunctional HCN ion channels in neurological diseases
por: DiFrancesco, Jacopo C., et al.
Publicado: (2015)

Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectives
por: Wang, Junhui
Publicado: (2023)

Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
por: Borja, Gabriel B., et al.
Publicado: (2022)

Editorial: “Small molecules targeting transmembrane receptors and ion channels in drug discovery”
por: Vitale, Rosa Maria, et al.
Publicado: (2023)

Insights on therapeutic potential of clemastine in neurological disorders
por: Jiang, Sufang, et al.
Publicado: (2023)

Editorial: Advances in understanding synaptic function and its dysfunction in neurological disorders
por: Mohammad, Farhan, et al.
Publicado: (2023)

Editorial: Recent advancements in modeling and simulations of ion channels
por: Furini, Simone, et al.
Publicado: (2022)

Glymphatic system: an emerging therapeutic approach for neurological disorders
por: Gao, Ying, et al.
Publicado: (2023)

Acid-sensing ion channels: potential therapeutic targets for neurologic diseases
por: Liu, Sha, et al.
Publicado: (2015)

Editorial: Cerebrospinal fluid dynamics and intracranial pressure elevation–Novel insights on molecular and physiological mechanisms, and implications for neurological disease
por: Patabendige, Adjanie, et al.
Publicado: (2022)

Editorial: Mitochondrial dysfunction as a target in neurodegenerative diseases
por: Perrone, Lorena
Publicado: (2023)

Editorial: Neuronopathic lysosomal storage diseases - specific neuronal characteristics and therapeutic approaches
por: Flunkert, Stefanie, et al.
Publicado: (2022)

Editorial: Synaptic Failure and Circuits' Impairment—Cognitive and Neurological Disorders—Moving a Step Forward
por: Ahmed, Touqeer, et al.
Publicado: (2022)

Editorial: The molecular mechanisms of epilepsy and potential therapeutics
por: Engel, Tobias, et al.
Publicado: (2022)

Acid-sensing ion channels (ASICs): therapeutic targets for neurological diseases and their regulation
por: Kweon, Hae-Jin, et al.
Publicado: (2013)

Orchestration of Ion Channels and Transporters in Neocortical Development and Neurological Disorders
por: Bando, Yuki, et al.
Publicado: (2022)

Editorial: Pharmacological Aspects of Ligand-Gated Ion Channels as Targets of Natural and Synthetic Agents
por: Mattei, César, et al.
Publicado: (2022)

Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications
por: Lu, Huan-Jun, et al.
Publicado: (2023)

Mitochondrial protein dysfunction in pathogenesis of neurological diseases
por: Wang, Liang, et al.
Publicado: (2022)

Delineating an extracellular redox-sensitive module in T-type Ca(2+) channels
por: Huang, Dongyang, et al.
Publicado: (2020)

Acid-sensing ion channel 3 is required for agmatine-induced histamine-independent itch in mice
por: Zhou, Guo-Kun, et al.
Publicado: (2023)

Editorial: Molecular mechanisms in neural development, related disorders, and therapeutic treatments
por: Kumar, Vijay, et al.
Publicado: (2023)

Editorial: Stress, pain or drug addiction: epigenetics, biological mechanisms and therapeutics
por: Kim, Hee Young, et al.
Publicado: (2023)

Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders
por: Tian, Zhen, et al.
Publicado: (2022)

Choroid plexus epithelium and its role in neurological diseases
por: Liu, Ruizhen, et al.
Publicado: (2022)

Neuron-astrocyte omnidirectional signaling in neurological health and disease
por: Pathak, Dhruba, et al.
Publicado: (2023)

Editorial: Primary cilia as therapeutic targets
por: Nishimura, Yuhei, et al.
Publicado: (2023)

Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases
por: Lam, Simon, et al.
Publicado: (2022)

Editorial: “Role of Ribonucleoprotein Complexes in Neurodevelopment and in the Physiopathology of Neurological Diseases”
por: Gwizdek, Carole, et al.
Publicado: (2021)

Editorial: Retinal Changes in Neurological Diseases
por: Sharma, Samridhi, et al.
Publicado: (2022)

Editorial: New GPCR targets and modulators to treat CNS disorders
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Editorial: The molecular mechanisms and potential drug targets for remyelination and neuroregeneration
por: Rutkowska, Aleksandra, et al.
Publicado: (2023)

Editorial: Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease
por: Bharadwaj, Shiv, et al.
Publicado: (2023)

Smooth muscle Acid-sensing ion channel 1a as a therapeutic target to reverse hypoxic pulmonary hypertension
por: Garcia, Selina M., et al.
Publicado: (2022)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Editorial: Molecular mechanisms of neuropsychiatric diseases
por: Moreira-Rodrigues, Mónica, et al.
Publicado: (2022)

Hapln2 in Neurological Diseases and Its Potential as Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2019)

Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases
por: Soares, Milena B. P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3isk15qgguba6hqh4dm8ln11b0